Abstract
Once diagnosed with gestational diabetes mellitus (GDM), a woman has a sevenfold increased risk of developing type 2 diabetes relative to women who do not have diabetes during pregnancy. In addition, up to one third of women with GDM have overt diabetes, impaired fasting glucose, or impaired glucose tolerance identified during postpartum glucose screening completed within 6 to 12 weeks. Therefore, the American Diabetes Association, the World Health Organization, and the American College of Obstetricians and Gynecologists currently recommend postpartum glucose screening following GDM. However, despite this recommendation, in many settings the majority of women with GDM fail to return for postpartum glucose testing. Studies conducted to date have not comprehensively examined the health care system, the physician, or the patient determinants of successful screening. These studies are required to help develop standard clinical procedures that enable and encourage all women to return for postpartum glucose screening following GDM.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Hunt KJ, Schuller KL: The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007, 34:173–199, vii.
Golden SH, Bennett WL, Baptist-Roberts K, et al.: Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. Gend Med 2009, 6(Suppl 1):109–122.
Baptiste-Roberts K, Barone BB, Gary TL, et al.: Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 2009, 122:207–214.e4.
•• Bellamy L, Casas JP, Hingorani AD, Williams D: Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773–1779. This study is a recent meta-analysis that reports a sevenfold increased risk of developing type 2 diabetes in women who had a pregnancy with GDM relative to women who did not have diabetes during pregnancy.
Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862–1868.
Kjos SL, Peters RK, Xiang A, et al.: Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 1995, 44:586–591.
Lobner K, Knopff A, Baumgarten A, et al.: Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006, 55:792–797.
Peters RK, Kjos SL, Xiang A, Buchanan TA: Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996, 347:227–230.
Schaefer-Graf UM, Buchanan TA, Xiang AH, Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 2002, 186:751–756.
Dawson SI: Glucose tolerance in pregnancy and the long-term risk of cardiovascular disease. Diabetes Res Clin Pract 2009, 85:14–19.
Retnakaran R, Qi Y, Connelly PW, et al.: Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010, 95:670–677.
Retnakaran R, Shah BR: Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009, 181:371–376.
Conway DL, Langer O: Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 1999, 181:610–614.
Hunt KJ, Conway DL: Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 2008, 198:404.e1–404.e6.
Retnakaran R, Qi Y, Sermer M, Connelly PW, et al.: Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008, 31:2026–2031.
Greenberg LR, Moore TR, Murphy H: Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1995, 86:97–101.
Kjos SL, Buchanan TA, Greenspoon JS, et al.: Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol 1990, 163(1 Pt 1):93–98.
Almario CV, Ecker T, Moroz LA, et al.: Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am J Obstet Gynecol 2008, 198:528.e1–528.e5.
Dietz PM, Vesco KK, Callaghan WM, et al.: Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy. Obstet Gynecol 2008, 112:868–874.
Ferrara A, Peng T, Kim C: Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2009, 32:269–274.
Kim C, Tabaei BP, Burke R, et al.: Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006, 96:1643–1648.
Kwong S, Mitchell RS, Senior PA, Chik CL: Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care 2009, 32:2242–2244.
Russell MA, Phipps MG, Olson CL, et al.: Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006, 108:1456–1462.
Smirnakis KV, Chasan-Taber L, Wolf M, et al.: Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 2005, 106:1297–1303.
World Health Organization: Report of a WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization. Department of Noncommunicable Disease Surveillance; 1999.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [no authors listed]. Diabetes Care 1997, 20:1183–1197.
Genuth S, Alberti KG, Bennett P, et al.: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160–3167.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl 1):S62–S67.
Metzger BE, Buchanan TA, Coustan DR, et al.: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(Suppl 2):S251–S260.
•• Committee on Obstetric Practice: ACOG Committee Opinion No. 435: postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus. Obstet Gynecol 2009, 113:1419–1421. This ACOG committee opinion was published following the release of results from the HAPO (Hyperglycemia and Adverse Pregnancy Outcomes) study. HAPO is a large prospective study demonstrating the correlation between increasing hyperglycemia and increased rates of fetal overgrowth.
American Diabetes Association: Standards of medical care in diabetes—2009. Diabetes Care 2009, 32(Suppl 1):S13–S61.
Baker AM, Brody SC, Salisbury K, et al.: Postpartum glucose tolerance screening in women with gestational diabetes in the state of North Carolina. N C Med J 2009, 70:14–19.
Gabbe SG, Gregory RP, Power ML, et al.: Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004, 103:1229–1234.
Morrison MK, Collins CE, Lowe JM: Postnatal testing for diabetes in Australian women following gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2009, 49:494–498.
Ogonowski J, Miazgowski T: The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res Clin Pract 2009, 84:239–244.
Clark HD, Graham ID, Karovitch A, Keely EJ: Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 2009, 200:634.e1–634.e7.
Chiasson JL, Josse RG, Gomis R, et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002, 359:2072–2077.
Gerstein HC, Yusuf S, Bosch J, et al.: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006, 368:1096–1105.
Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.
Pan XR, Li GW, Hu YH, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537–544.
Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350.
Acknowledgment
This work was supported in part by a grant from the National Center on Minority and Health Disparities/National Institutes of Health (R01MD004251-02).
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hunt, K.J., Logan, S.L., Conway, D.L. et al. Postpartum Screening Following GDM: How Well Are We Doing?. Curr Diab Rep 10, 235–241 (2010). https://doi.org/10.1007/s11892-010-0110-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-010-0110-x